« Back to Record
Citation APA

Cornely, O. A., Maertens, J., Bresnik, M., Ebrahimi, R., Ullmann, A., Bouza, E., Heussel, C. P., Lortholary, O., Rieger, C., Boehme, A., Aoun, M., Horst, H.-A., Thiebaut, A., Ruhnke, M., Reichert, D., Vianelli, N., Krause, S. W., Olavarria, E., Herbrecht, R., & AmBiLoad Trial Study Group, (2007). Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clinical infectious diseases, 44(10), 1289-1297. doi:10.1086/514341


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/120201

Cornely, O. A., Maertens, J., Bresnik, M., Ebrahimi, R., Ullmann, A., Bouza, E., Heussel, C. P., Lortholary, O., Rieger, C., Boehme, A., Aoun, M., Horst, H.-A., Thiebaut, A., Ruhnke, M., Reichert, D., Vianelli, N., Krause, S. W., Olavarria, E., Herbrecht, R., & AmBiLoad Trial Study Group, (2007). Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clinical infectious diseases, 44(10), 1289-1297. doi:10.1086/514341